The BCR gene encodes a novel serine/threonine kinase activity within a single exon - PubMed (original) (raw)
The BCR gene encodes a novel serine/threonine kinase activity within a single exon
Y Maru et al. Cell. 1991.
Abstract
Sequences encoded by the first exon of BCR that bind to the ABL SH2 domain are essential for the activation of the ABL tyrosine kinase and transforming potential of the chimeric BCR-ABL oncogene. The normal cellular BCR gene encodes a 160,000 dalton phosphoprotein associated with a serine/threonine kinase activity, but it shows only weak dispersed homologies to protein kinases. p160c-BCR was purified to apparent homogeneity as an oligomer of greater than 600,000 daltons that contains autophosphorylation activity and transphosphorylation activity for several protein substrates. A region containing paired cysteine residues within the 426 amino acids encoded by the first exon of BCR is essential for its novel phosphotransferase activity, which overlaps with the strong SH2-binding regions. The recent demonstration of a GTPase-activating function within the C-terminal portion of BCR suggests that the protein kinase and SH2-binding domains may work in concert with other regions of the molecule in intracellular signalling processes.
Similar articles
- BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner.
Pendergast AM, Muller AJ, Havlik MH, Maru Y, Witte ON. Pendergast AM, et al. Cell. 1991 Jul 12;66(1):161-71. doi: 10.1016/0092-8674(91)90148-r. Cell. 1991. PMID: 1712671 - BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.
Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J, et al. Pendergast AM, et al. Cell. 1993 Oct 8;75(1):175-85. Cell. 1993. PMID: 8402896 - Inhibition of the Bcr-Abl oncoprotein by Bcr requires phosphoserine 354.
Hawk N, Sun T, Xie S, Wang Y, Wu Y, Liu J, Arlinghaus RB. Hawk N, et al. Cancer Res. 2002 Jan 15;62(2):386-90. Cancer Res. 2002. PMID: 11809685 - Bcr: a negative regulator of the Bcr-Abl oncoprotein in leukemia.
Arlinghaus RB. Arlinghaus RB. Oncogene. 2002 Dec 9;21(56):8560-7. doi: 10.1038/sj.onc.1206083. Oncogene. 2002. PMID: 12476302 Review. - Mutated tyrosine kinases as therapeutic targets in myeloid leukemias.
Sattler M, Scheijen B, Weisberg E, Griffin JD. Sattler M, et al. Adv Exp Med Biol. 2003;532:121-40. doi: 10.1007/978-1-4615-0081-0_11. Adv Exp Med Biol. 2003. PMID: 12908554 Review.
Cited by
- JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies.
Downes CE, McClure BJ, McDougal DP, Heatley SL, Bruning JB, Thomas D, Yeung DT, White DL. Downes CE, et al. Front Cell Dev Biol. 2022 Jul 12;10:942053. doi: 10.3389/fcell.2022.942053. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35903543 Free PMC article. Review. - Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone.
Malik V, Radhakrishnan N, Kaul SC, Wadhwa R, Sundar D. Malik V, et al. Biomolecules. 2022 Jan 26;12(2):212. doi: 10.3390/biom12020212. Biomolecules. 2022. PMID: 35204712 Free PMC article. - NHD2-15, a novel antagonist of Growth Factor Receptor-Bound Protein-2 (GRB2), inhibits leukemic proliferation.
Lewis TR, Smith J, Griffin K, Aguiar S, Rueb KF, Holmberg-Douglas N, Sampson EM, Tomasetti S, Rodriguez S, Stachura DL, Arpin CC. Lewis TR, et al. PLoS One. 2020 Aug 11;15(8):e0236839. doi: 10.1371/journal.pone.0236839. eCollection 2020. PLoS One. 2020. PMID: 32780746 Free PMC article. - BCR: a promiscuous fusion partner in hematopoietic disorders.
Peiris MN, Li F, Donoghue DJ. Peiris MN, et al. Oncotarget. 2019 Apr 12;10(28):2738-2754. doi: 10.18632/oncotarget.26837. eCollection 2019 Apr 12. Oncotarget. 2019. PMID: 31105873 Free PMC article. Review. - Induction of apoptosis in imatinib sensitive and resistant chronic myeloid leukemia cells by efficient disruption of bcr-abl oncogene with zinc finger nucleases.
Huang N, Huang Z, Gao M, Luo Z, Zhou F, Liu L, Xiao Q, Wang X, Feng W. Huang N, et al. J Exp Clin Cancer Res. 2018 Mar 20;37(1):62. doi: 10.1186/s13046-018-0732-4. J Exp Clin Cancer Res. 2018. PMID: 29554925 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous